Onderzoeksoutput per jaar
Begeleid werk per jaar
Begeleid werk
- 14 resultaten
Zoekresultaten
-
2025
Exploring novel therapeutic approaches for the treatment of hematological malignancies: a focus on autophagy and immunotherapy
Visser, N., 2025, [Groningen]: University of Groningen. 267 blz.Onderzoeksoutput
Open AccessBestand8 Downloads (Pure) -
Multifaceted approaches to tumor microenvironment modulation and immune checkpoint targeting
Melo Gallegos, V. A., 2025, [Groningen]: University of Groningen. 211 blz.Onderzoeksoutput
Open AccessBestand205 Downloads (Pure) -
2024
Exploring novel immune checkpoints and targeted delivery strategies for ovarian cancer therapy
Bilemjian, V., 2024, [Groningen]: University of Groningen. 159 blz.Onderzoeksoutput
Open AccessBestand173 Downloads (Pure) -
Navigating the path of Cancer Immunotherapeutics: Novel Targets and Innovative Development Tools
Álvarez Freile, J., 2024, [Groningen]: University of Groningen. 190 blz.Onderzoeksoutput
Open AccessBestand531 Downloads (Pure) -
Towards improving cancer immunotherapy: development of novel antibody-based therapeutics and drug delivery systems
Nelemans, L. C., 2024, [Groningen]: University of Groningen. 171 blz.Onderzoeksoutput
Open AccessBestand66 Downloads (Pure) -
2023
Advancing Cancer Immunotherapy with Nanomedicine
Choukrani, G., 2023, [Groningen]: University of Groningen. 207 blz.Onderzoeksoutput
Open AccessBestand806 Downloads (Pure) -
Novel T cell biomarkers and the development of immunotherapeutic anti-tumor strategies
Vlaming, M., 2023, [Groningen]: University of Groningen. 273 blz.Onderzoeksoutput
Open AccessBestand563 Downloads (Pure) -
Towards personalized cancer management: diagnosis and (immuno)therapy
Lin, Y., 2023, [Groningen]: University of Groningen. 239 blz.Onderzoeksoutput
Open AccessBestand405 Downloads (Pure) -
2022
Innate immune checkpoint inhibitors for treatment of Diffuse Large B-cell Lymphoma
Bouwstra, R., 2022, [Groningen]: University of Groningen. 219 blz.Onderzoeksoutput
Open AccessBestand1170 Downloads (Pure) -
2017
Novel antibody-based drugs for PD-L1 and TRAIL-R targeted cancer immunotherapy
Hendriks, D., 2017, [Groningen]: Rijksuniversiteit Groningen. 163 blz.Onderzoeksoutput
Open AccessBestand4177 Downloads (Pure) -
Towards novel cancer (immuno)therapy using TRAIL and Galectin-9
Wiersma, V. R., 2017, [Groningen]: Rijksuniversiteit Groningen. 184 blz.Onderzoeksoutput
Open AccessBestand1554 Downloads (Pure) -
2016
TNF receptor superfamily-based targeted cancer immunotherapy
He, Y., 2016, [Groningen]: University of Groningen. 152 blz.Onderzoeksoutput
Open AccessBestand1482 Downloads (Pure) -
2013
Immunologic aspects of ovarian cancer
Gooden, M. J. M., 2013, Groningen: s.n.. 175 blz.Onderzoeksoutput
Open AccessBestand3225 Downloads (Pure) -
2012
Targeted delivery of TRAIL for immunotherapy of ovarian cancer
Bruyn, M. D., 2012, Groningen: s.n.. 173 blz.Onderzoeksoutput
Open AccessBestand396 Downloads (Pure)